Monterey Bio Acquisition Corp

Monterey Bio Acquisition Corp. is a blank check company that was formed for the purpose of effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 23, 2020 and is headquartered in New York, NY.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Monterey Innovation Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 23, 2020 and is headquartered in New York, NY.

NEW YORK , March 10, 2023 /PRNewswire/ -- Monterey Bio Acquisition Corporation (Nasdaq: MTRYU) today announced a rebrand to Monterey Innovation Acquisition Corp. ("Monterey Innovation" or "the Company"), expanding its acquisition strategy to include a broader universe of disruptive technology targets, which is further enabled by key additions to the board of directors and changes to the Company's management team.   Along with existing directors, James Neal, Frances Heller, and Sandip Patel, Monterey Innovation proudly welcomes Chris Coleman, Jory Des Jardins, and Roderick Hardamon to the board, with Jonas Grossman assuming the Executive Chairman role.

Monterey Bio Acquisition Corp. Announces Rebrand and Management Changes

NEW YORK, Nov. 17, 2021 /PRNewswire/ -- Monterey Bio Acquisition Corporation (the "Company") announced today that, commencing November 22, 2021, holders of the units sold in the Company's initial public offering may elect to separately trade shares of the Company's common stock and warrants included in the units. Any units not separated will continue to trade on the Nasdaq Global Market ("Nasdaq") under the symbol "MTRYU," and the shares of common stock and warrants that are separated will trade on Nasdaq under the symbols "MTRY" and "MTRYW," respectively.

Monterey Bio Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing November 22, 2021

NEW YORK, Oct. 5, 2021 /PRNewswire/ -- Monterey Bio Acquisition Corporation ("Monterey Bio" or the "Company") (Nasdaq: MTRYU) today announced the closing of its previously announced initial public offering of 10,000,000 units, at a price to the public of $10.00 per unit. The Company also announced that the underwriter had exercised in full its option to purchase 1,500,000 additional units, with the option expected to close on October 6, 2021, subject to customary closing conditions.

Monterey Bio Acquisition Corporation Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Units

News for Monterey Bio Acquisition Corp Stock (MTRYU)